Drug Development Progress: Positive clinical trial results typically lead to stock price increases, while negative or delayed results can cause price declines.

Regulatory Approvals: FDA approval of IMNM.US's drugs is a major catalyst that significantly increases the stock price. Rejection or delays negatively impact the stock.

Market Sentiment: Overall investor optimism or pessimism about the biotechnology sector can influence IMNM.US's stock price, irrespective of company-specific news.

Financial Performance: Revenue, profitability, and cash flow reports influence investor confidence and affect the stock price. Poor financial results can lead to selling pressure.

Competition: The presence of competing drugs or therapies from other companies can impact IMNM.US's market share and revenue potential, affecting the stock price.

Partnerships & Acquisitions: Strategic collaborations or potential acquisitions can boost investor confidence and positively impact the stock price.

News & Media Coverage: Positive or negative news articles and media reports about IMNM.US or its products can sway investor sentiment and affect the stock price.

Economic Conditions: Broader economic factors such as interest rates, inflation, and overall economic growth can impact investor risk appetite and influence IMNM.US's stock price.

Intellectual Property: The strength and protection of IMNM.US's patents and intellectual property rights are critical for its long-term value and can affect the stock price.